Epigenomics AG (EPGNF)
OTCMKTS · Delayed Price · Currency is USD
1.120
+0.170 (17.89%)
At close: Jul 18, 2025
Epigenomics AG Market Cap
Epigenomics AG has a market cap or net worth of $915.76 thousand as of February 12, 2026. Its market cap has decreased by -19.46% in one year.
Market Cap
915.76K
Enterprise Value
13.52M
Revenue
4.70K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.12
Market Cap Chart
Since September 22, 2014, Epigenomics AG's market cap has decreased from 66.74M to 915.76K, a decrease of -98.63%. That is a compound annual growth rate of -31.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 915.76K | -1.36% |
| Dec 30, 2025 | 928.42K | -8.71% |
| Dec 30, 2024 | 1.02M | -42.03% |
| Dec 29, 2023 | 1.75M | -75.69% |
| Dec 30, 2022 | 7.22M | -22.11% |
| Dec 30, 2021 | 9.27M | -60.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aspira Women's Health | 16.96M |
| Psychemedics | 10.16M |
| Hypha Labs | 5.13M |
| Stella Diagnostics | 4.67M |
| Centogene | 3.16M |
| InVitro International | 2.56M |
| IDenta | 1.01M |
| ProPhase Labs | 775.05K |